New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›State Street Investment Management›XLVI

XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

Active ETF Equity

Not rated

The XLVI Exchange Traded Fund (ETF) is provided by State Street Investment Management. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

$27.01

-$0.063 (-0.23%) today

1:31 PM 08/14/26 Open

1D price range

$27.01$27.01

52W price range

$24.24$27.09

YTD Perf.

+10.08%

YTD Flows

Annualized volatility

Fund AuM

€20M

Share class AuM

€20M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US81369Y7461

TER

0.35%

Inception date

7/30/2025

Issuer

State Street Investment Management

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
XLV State Street Health Care Select Sector SPDR ETF	+2.38%
SXLV State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF	+2.38%
ZXLV BMO SPDR Health Care Select Sector Index ETF	+1.75%
IUHC iShares S&P 500 Health Care Sector UCITS ETF	+2.38%
453640 SAMSUNG Kodex S&P500 Health Care ETF	+2.26%
XUHC Xtrackers MSCI USA Health Care UCITS ETF	+2.35%
IYH iShares U.S. Healthcare ETF	+2.65%
ZWHC BMO Covered Call Health Care ETF	+1.74%
FHLC Fidelity MSCI Health Care Index ETF	+2.31%
VHT Vanguard Health Care ETF	+2.31%
HHL Harvest Healthcare Leaders Income ETF	+2.42%
LMAX Hamilton Healthcare Yield Maximizer ETF	+1.58%
RSPH Invesco S&P 500® Equal Weight Health Care ETF	+2.81%
HIG Brompton Global Healthcare Income & Growth ETF	+1.14%
XDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF	+2.81%

API

PerformanceDec 31, 2025 - Aug 13, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

100.33%

Consumer Non-Cyclicals

2.37%

Latest XLVI news

No content available for this fund

FAQ about XLVI

XLVI is a Active ETF. This ETF provides exposure to Large Cap US Health Care Equities.

XLVI carries a total expense ratio (TER) of 0.35%, indicating the annual cost for holding the fund.

XLVI was introduced to the market on July 30, 2025. It trades on United States

State Street Health Care Select Sector SPDR Premium Income Fund, XLVI, is provided by State Street Investment Management. Learn more about State Street Investment Management here.

XLVI oversees €20M in assets as of August 13, 2026.

XLVI follows a distributing dividend policy, meaning it pays out income to investors. As of August 13, 2026, its 12-month trailing yield was 12.39%.

As of June 30, 2026, XLVI has significant geographic allocations in USA and Ireland.

As of June 30, 2026, XLVI focuses largely on Healthcare and Consumer Non-Cyclicals.

As of June 30, 2026, XLVI holds 59 positions in its portfolio, with 74.76% of assets concentrated in its top 15 holdings.

As of June 30, 2026, XLVI top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

The base currency of XLVI is USD.

Top 10 holdings

Data as of 06/30/26

Eli Lilly & Co.

17.01%

Johnson & Johnson

10.96%

AbbVie, Inc.

7.97%

UnitedHealth Group, Inc.

6.77%

Merck & Co., Inc.

5.69%

Amgen, Inc.

3.50%

Thermo Fisher Scientific, Inc.

3.34%

Abbott Laboratories

2.83%

Gilead Sciences, Inc.

2.81%

Intuitive Surgical, Inc.

2.53%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

State Street Health Care Select Sector SPDR Premium Income Fund

FAQ about XLVI

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US